Passage Bio, Inc.
Passage Bio, Inc is a Philadelphia-based biotechnology company developing genetics-based medicines.
3
Funding Rounds
$379.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Wi**** (e************ | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma**** Go*** | - | - | - |
| ta****** ya**** | - | - | |
| Sa*** Is**** J.** | - | - | - |
| At**** Co*********** | - | - | |
| Th**** Wo***** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Br*** Go******* | - | - |
Funding
Funding series
Funding Series Analysis
The company Passage Bio, Inc. has raised a total of $379.5m in funding over 3 rounds.
Key Insights:
- Passage Bio, Inc. Venture round, January 21, 2021: $154m
- Passage Bio, Inc. Series B round, September 4, 2019: $110m
- Passage Bio, Inc. Series A round, February 15, 2019: $115.5m
Passage Bio, Inc. Venture round, January 21, 2021
$154m
Passage Bio, Inc. Series B round, September 4, 2019
$110m
Passage Bio, Inc. Series A round, February 15, 2019
$115.5m
Industries
Passage Bio, Inc. is active in the following industries:
- Technology
- Rare disease
- Biology
- Biotechnology
- Regenerative medicine
- Life science
- Engineering
- Tissue engineering
- Healthcare
- Biomedical engineering
- Therapeutics
- Biopharmaceutical